Bosh sahifa068270 • KRX
add
Celltrion Inc
Yopilish kursi
178 800,00 ₩
Kunlik diapazon
174 000,00 ₩ - 179 000,00 ₩
Yillik diapazon
144 615,31 ₩ - 193 223,36 ₩
Bozor kapitalizatsiyasi
40,53 trln KRW
Oʻrtacha hajm
508,52 ming
Narx/foyda
69,18
Dividend daromadliligi
0,39%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 841,91 mlrd | 14,24% |
Joriy xarajat | 293,45 mlrd | 0,76% |
Sof foyda | 108,67 mlrd | 384,28% |
Sof foyda marjasi | 12,91 | 324,67% |
Har bir ulushga tushum | 508,65 | 414,31% |
EBITDA | 220,36 mlrd | 49,86% |
Amaldagi soliq stavkasi | 44,58% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 970,72 mlrd | 5,45% |
Jami aktivlari | 20,96 trln | 4,00% |
Jami passivlari | 3,68 trln | 16,94% |
Umumiy kapital | 17,28 trln | — |
Tarqatilgan aksiyalar | 233,59 mln | — |
Narxi/balansdagi bahosi | 2,44 | — |
Aktivlardan daromad | 1,78% | — |
Kapitaldan daromad | 1,90% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 108,67 mlrd | 384,28% |
Operatsiyalardan naqd pul | 113,45 mlrd | 206,45% |
Sarmoyadan naqd pul | -54,86 mlrd | -55,15% |
Moliyadan naqd pul | -243,49 mlrd | -242,88% |
Naqd pulning sof oʻzgarishi | -167,36 mlrd | -191,58% |
Boʻsh pul | 226,51 mlrd | 169,09% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
2 391
